Trial Profile
First-in-human study of LMB-763 in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Jul 2017
Price :
$35
*
At a glance
- Drugs Nidufexor (Primary)
- Indications Non-alcoholic steatohepatitis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 07 Jul 2017 New trial record